Guidance document - Nonprescription oral adult expectorant cough and cold labelling standard

Guidance document - Nonprescription oral adult expectorant cough and cold labelling standard This labelling standard describes the requirements necessary to receive marketing authorization (Drug identification number (DIN)) for oral expectorant nonprescription product containing guaifenesin as a single ingredient for use in adults and children 12 years of age and older to relieve symptoms of common cold. 2021-09-09 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyNon-prescription oral adult expectorant cough and coldlabelling standardmarket authorizationdextromethorphandextromethorphan hydrobromide Guidance document - Nonprescription oral adult expectorant cough and cold labelling standardHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/nonprescription-oral-adult-expectorant-cough-cold-labelling-standard.html Guidance document - Nonprescription oral adult expectorant cough and cold labelling standardHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/medicaments-vente-libre-normes-etiquetages-produits-pharmaceutiques/norme-etiquetage-medicaments-adultes-vendus-sans-ordonnance-contre-toux-rhume-administres-voie-orale.html

This labelling standard describes the requirements necessary to receive marketing authorization (Drug identification number (DIN)) for oral expectorant nonprescription product containing guaifenesin as a single ingredient for use in adults and children 12 years of age and older to relieve symptoms of common cold.

Data and Resources

Similar records